Essen Biotech
Clinical trials sponsored by Essen Biotech, explained in plain language.
-
Personalized cell therapy trial offers new hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new type of cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors will analyze a patient's tumor to select a specific target, then infuse specially engineered immune cells (CAR-NK cells) from a heal…
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New 'Off-the-Shelf' cell therapy trial offers hope for tough cancers
Disease control Recruiting nowThis study is testing a new type of treatment called EBNK-001, which uses donated immune cells (Natural Killer cells) to fight cancer. It is for adults with advanced solid tumors that have grown or returned after standard treatments. The main goals are to find a safe dose and see…
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC